| Literature DB >> 30150086 |
Juliana Leitzke Santos de Souza1, Victoria Burmann da Silva Guimarães2, Angela Diniz Campos3, Rafael Guerra Lund4.
Abstract
Pyroligneous extract is applied in diverse areas as an antioxidant, an antimicrobial, and an anti-inflammatory agent. The discovery of new cost-effective antimicrobial agents of natural origin remains a challenge for the scientific community. This study aimed to conduct a systematic review and a technological forecasting of the existent evidence regarding the use of pyroligneous extract as a potential antimicrobial agent. Studies were identified through an investigation of various electronic databases: PubMed, SciFinder, Web of Science, Scopus, Scielo, Google scholar, and ProQuest. Patents were searched through INPI, Google patents, Espacenet, Patents online, USPTO, and WIPO. The literature on antimicrobial activity of pyroligneous extract are limited given the short duration of studies and variability in study design, use of pyroligneous preparations, and reports on results. However, evidence suggests the potential of pyroligneous extract as a natural antimicrobial agent. The most studied activity was the role of PE as a food preservative. However, pyroligneous extracts are also effective against pathogenic bacteria in the oral microflora and treatment of candidal infections. Further research is needed using standardized preparations of pyroligneous extracts to determine their long-term effectiveness and ability as antimicrobial agents.Entities:
Keywords: Antimicrobial; Food preservation; Infections; Pharmaceutical; Preservative
Mesh:
Substances:
Year: 2018 PMID: 30150086 PMCID: PMC6328853 DOI: 10.1016/j.bjm.2018.07.001
Source DB: PubMed Journal: Braz J Microbiol ISSN: 1517-8382 Impact factor: 2.476
Search strategy.
| Search strategy |
|---|
| #1 (“wood vinegar” OR “pyroligneous acid” OR “pyroligneous extract” OR “pyroligneous” OR “liquid smoke”) |
| AND |
| #2 (“Anti-Infective Agents” [MESH] “Antimicrobial activity” OR “Antibacterial activity” OR “Antifungal activity” OR “Anti-Infective Agents” OR “Agents, Anti-Infective” OR “Anti Infective Agents” OR “Antiinfective Agents” OR “Agents, Antiinfective” OR “Microbicides” OR “Antimicrobial Agents” OR “Agents, Antimicrobial” OR “Anti-Microbial Agents” OR “Agents, Anti-Microbial” OR “Anti Microbial Agents”) |
| #1 Topic: (“wood vinegar”) OR Topic: (“pyroligneous acid”) OR Topic: (“pyroligneous extract”) OR Topic: (“pyroligneous”) OR Topic: (“liquid smoke”) |
| AND |
| #2 Topic: (“antimicrobial activity”) OR Topic: (“Anti-Infective Agents”) |
| #1 (“wood vinegar”) OR (“pyroligneous acid”) OR (“pyroligneous extract”) OR (“pyroligneous”) |
| AND |
| #2 (“antimicrobial activity”) OR (“Anti-Infective Agents”) |
| #1 (“antimicrobial activity of Wood Vinegar”) OR #2 (“antimicrobial activity of pyroligneous acid”) OR #3 (“antimicrobial activity of pyroligneous extract”) |
| #1 (“wood vinegar”) OR (“pyroligneous acid”) OR (“pyroligneous extract”) OR (“pyroligneous”) OR (“liquid smoke”) |
| AND |
| #2 (“antimicrobial activity”) OR (“Anti-Infective Agents”) |
| #1 (wood vinegar) OR (pyroligneous acid) OR (pyroligneous extract) OR (pyroligneous) OR (liquid smoke) |
| AND |
| #2 (antimicrobial activity) |
| #1 (wood vinegar) OR (pyroligneous acid) OR (pyroligneous extract) OR (pyroligneous) OR (liquid smoke) |
| AND |
| #2 (antimicrobial activity) |
Demographic data from articles and patents considered in this study.
| Microorganism tested | Pyroligneous extract source | Concentrations | Methods | Application area | |||||
|---|---|---|---|---|---|---|---|---|---|
| Assays | Sample size (per group)/repetition of assays | Period | Positive control | Negative control | |||||
| Seven commercial smoke condensates. | 0.05, 0.1, 0.2 and 0.4% for L1, L4, S2 and S3; 0.2, 0.3, 0.4, 0.6 and 0.8% for L2; 0.5, 1, 2, 4, 8% for L3 and 0.5, 1, 1.5% for S2. | Agar dilution methods | 24 and 48 h | TSA and MRS agar without smoke inoculated with the working cultures. | No | As food preservative. | |||
| Four commercial smoke condensates. | 1% for the dried extract, 0.4% for L1, 0.6% for L2 and 4% for L3. | Broth and agar dilution methods | 0, 1, 2, 7, 14 and 21 days | Inoculated TSB without smoke extracts served as positive controls. | Non-inoculated flasks were used for sterility control. | As food preservative. | |||
| Nine commercial liquid smokes. | Fractions (v/v) were 0.5%, 0.75%, 1.0%, 1.5%, and 2.0% to 10.0%. | Broth or agar dilution methods | 24 h | Petri dishes with no smoke extracts that were inoculated. | No. | As food preservative. | |||
| Two commercial liquid smokes. | Dipped for 5, 15, 30, 60, and 90 s with liquid smoke extract. | Direct spiral plating methods | 10 weeks | Frankfurters not dipped. | No. | As food preservative. | |||
| Four commercial liquid smokes. | 2% | Direct spiral plating methods | 2 and 4 weeks | Three samples of each meat product. | No. | As food preservative. | |||
| Eight commercial liquid smoke extracts. | 96%–0.375%. | Broth microdilution method | 24 h | Control containing PBS solution. | No. | As food preservative. | |||
| Two commercial liquid smokes. | Viral inactivation assay | 6 h | As an agent for preventing viral epidemics in agricultural and human environments. | ||||||
| 104 | One commercial liquid smokes. | Serial dilutions of BPA ( | Maximum inhibitory dilution/agar method | 18 h | No. | For antibacterial infections in animals. | |||
| Four strains of pathogenic | Four extract of liquid smokes. | Between 0.39 and 100.00 mg/mL. | Disk diffusion method; broth dilution method; time-kill assay | 24 and 48 h | No. | As an antifungal agent especially to treat candidal infections. | |||
| Four extract of liquid smokes. | Between 0.39 and 100.00 mg/mL. | Disk diffusion method; broth dilution method; time-kill assay | 24 h | Chloramphenicol (Sigma, Germany) at the concentration of 30 μg/mL was used as a positive control. | Commercial antibiotic disk GF A (Whatman, England) with 6.0 mm. | As an antimicrobial agent against pathogenic bacteria. | |||
| Three commercial liquid smokes from Mesquite, Hickory and pecan shell. | Eight serial dilutions ranged to 48 and 0.375% (v/v). | Broth micro dilution/agar method | 24 h | Controls containing only PBS plus bacteria were included. | No | As food preservative. | |||
| Walnut tree branches. | Concentrations of 40, 20, 10, 5, 2.5, 1.25 and 0.625 mg/mL. | Disk diffusion and (EC50). | As natural germicide. | ||||||
| Concentrations of 50, 25, 12.5, 6.25, 3.125, 1.5625, 0.781 mg/mL. | Disk diffusion method. | 48 h | Sterile water. | No. | As germicide. | ||||
| Rice ( | Concentrations of 0.1%, 0.5%, and 1.0% (v/v). | Disk diffusion method. | 24 h | As antimicrobial flavor formulations for application to human foods and animal feeds. | |||||
| For | Three groups of 10 mice each. | 12/12 h for 48 h | PBS-treated control. | Vancomycin (20 mg/mL). | |||||
Patents data, antibacterial compositions and claims related to pyroligneous extracts antimicrobial activity.
| Patent | Country | Title | Year | Antibacterial composition | Claimed |
|---|---|---|---|---|---|
| US4308293 | United States | Antimicrobial treatment and preservation of animal feedstuffs | 1981 | Pyroligneous acid and pyroligneous acid complexes. | Preservative agents for the treatment of animal feedstuffs. |
| US4377187 | United States | Liquid smoke impregnated fibrous food casing | 1983 | Liquid smoke. | A fibrous reinforced cellulosic food casing with the impregnated liquid smoke providing antimycotic quality. |
| US5043174 | United States | Meat processing with Listeria monocytogene re-inoculation control stage | 1991 | Liquid smoke derivative product containing a minimum of carbonyl and phenol. | Compositions for antimicrobial treatment of food products. |
| JP2000160476 (A) | Production of carbon fiber and carbon fiber produced thereby | 2000 | Extract of mugwort ( | Carbon fiber that has antimicrobial activity. | |
| KR20030005075 (A) | Korean | Cosmetic composition containing pyroligneous acid solution | 2003 | The cosmetic composition contains 0.5 to 5.0% by weight of a pyroligneous acid solution, based on the total weight of the composition. | A cosmetic composition containing a pyroligneous acid solution with antimicrobial activity and antioxidant activity for protecting the skin. |
| KR20030014052 (A) | Korean | Natural biodeodorizing agent composition | 2003 | The Bacillus strain has a final concentration of 0.5x10 not 7 to 1x10 not 7, based on 3 to 5% pyroligneous solution. | A biodeodorizing agent composition with an excellent antimicrobial activity against putrefactive or pathogenic bacteria and a long-lasting deodorizing effect. |
| US20050175746 A1 | United States | Low flavor anti-microbials derived from smoke flavors | 2005 | Derivatives of liquid smoke. | Compositions for antimicrobial treatment of food products. |
| KR20060109757 (A) | Korean | Silver-ionized wood vinegar having enhanced antimicrobial activity and use thereof for improving or preventing disease caused by pathogenic bacteria | 2006 | The silver-ionized wood vinegar is prepared by ionizing silver in wood vinegar with electrolysis. | Compositions for antimicrobial activity. |
| KR1020070042868 | Korean | Pharmaceutical composition for ameliorating symptoms of atopic dermatitis without skin irritation Comprising refined nontoxic wood vinegar having no harmful materials | 2007 | Refined wood vinegar 24 wt.% of acetic acid, 0.05–0.15 wt.% of formic acid, 0.50–0.15 wt.% of propionic acid. | Pharmaceutical composition for ameliorating symptoms of atopic dermatitis and improving antimicrobial activity. |
| US20070212310 A1 | United States | Antimicrobial smoke flavor for oral microflora control | 2007 | Compositions that include low flavor antimicrobial liquid smoke derivatives. | Compositions and methods for inhibiting the growth of oral microbes in a subject. |
| US20090011096 | United States | Preservatives for food | 2009 | Combination of N long chain alkyl of di basic amino acid alkyl ester acid salt biocides with liquid smoke compositions. | Compositions for antimicrobial treatment of food products. |
Fig. 1Flow chart.